How Do I Find Eli Lilly Clinical Trials for Weight Loss?

To find Eli Lilly clinical trials for weight loss, start with Lilly’s Weight Management Research page or search ClinicalTrials.gov, then check each study’s recruiting status, location, eligibility, placebo possibility, visit schedule, and cost terms. Contact the listed study center to confirm open enrollment and complete screening; review the consent form before deciding whether to participate.
How do I find and apply for an Eli Lilly weight-loss clinical trial near me?
Start with Lilly’s Weight Management Research page, which is a starting point for finding Lilly studies. Each listing has study-specific availability and eligibility details, so a general weight-management page cannot tell you whether a particular location has an open slot.
Use this sequence to move from search results to a confirmed answer:
- Open Lilly’s research page and review the weight-management studies, or search ClinicalTrials.gov for Lilly-sponsored obesity or weight-loss trials.
- Open a study listing and check its status, participating locations, eligibility criteria, expected duration, visit count, and whether placebo assignment is possible.
- Contact the listed study center or Lilly’s Trial Information Center. Lilly lists telephone, email, and text options for prospective participants asking about studies.
- Ask whether the location is actively screening and has room for new participants. Listings can change; the TRIUMPH-8 page, for example, is marked ACTIVE_NOT_RECRUITING in the supplied ClinicalTrials.gov record.
- If the site is enrolling, ask how screening works and what records or appointments it requires. The study team determines eligibility, not the search listing alone.
This last confirmation matters: a trial can appear in a search while a specific location is not enrolling. The TRIUMPH-1 listing is completed, while TRIUMPH-8 is not recruiting, illustrating why readers should verify status both online and with the site.

What BMI and medical history requirements could affect eligibility for a Lilly obesity trial?
BMI, weight-related health conditions, past weight-loss efforts, and medical history can all affect eligibility, but the exact criteria depend on the trial. For example, the ClinicalTrials.gov record for Lilly-sponsored TRIUMPH-8 describes eligibility for adults with a BMI of at least 30, or at least 27 with a weight-related condition, plus at least one unsuccessful dieting attempt.
That example is not a universal Lilly cutoff. TRIUMPH-1 used similar example BMI thresholds and also required an unsuccessful dietary weight-loss effort, while the Lilly listing for LY3549492 gives an age range of 18–75 and its own key eligibility conditions. The study protocol and location determine which requirements apply.
Medical history can matter as much as BMI. The TRIUMPH-8 listing includes exclusions such as type 1 or type 2 diabetes, certain recent cardiovascular events, a history of pancreatitis, and a personal or family history of medullary thyroid carcinoma or MEN-2. These are examples from that trial, not a diagnosis or a blanket rule for every study.
When contacting a site, ask which criteria are checked before an in-person visit and which are assessed during screening. Share relevant medical-history information accurately with the study team so it can explain whether the specific protocol may fit.
Do Eli Lilly clinical trials pay participants, or reimburse travel expenses?
Payment or travel reimbursement depends on the individual study; the supplied sources do not state a standard Lilly payment amount. HHS says payment for research participation is generally permissible, but the study’s payment terms and conditions should be clearly described in its consent materials.
Before agreeing to screening or enrollment, ask the coordinator to explain these items in writing:
- Whether you or your insurer could be billed for tests, procedures, or study drugs.
- Which study-related care and procedures are covered by the study.
- Whether travel, parking, meals, childcare, or other participation-related expenses could arise and whether money is available to cover them.
- Whether there is participant payment, what conditions apply, and when payment is made.
- Where the consent form describes costs, reimbursement, payment, and any conditions tied to completing visits.
HHS’s questions for research volunteers specifically recommend asking whether participants or insurers may pay for tests, procedures, or study drugs, and whether researchers cover travel or other costs. Do not assume a trial is free or paid based on its sponsor; confirm the terms for that study and site.
The consent process is also the place to clarify reasonably foreseeable risks, study procedures, and whom to contact with concerns. HHS’s informed consent guidance says the information should explain the study’s purpose, expected duration, procedures, and applicable costs and payment terms.
Will I receive the study drug or could I be assigned a placebo?
You could be assigned a placebo in a randomized, placebo-controlled trial, so enrollment does not guarantee receipt of the active study drug. In the Lilly-sponsored TRIUMPH-8 and TRIUMPH-1 listings, participants may be assigned to retatrutide or placebo, with random assignment and double blinding described.
Randomization means participants are assigned among study groups according to the trial design; double blinding means participants and relevant study personnel do not know the assignment during the blinded part. The practical point is straightforward: ask which groups exist, how assignment works, whether any placebo period is planned, and what happens if your health needs change.
Compare the commitment before consenting. Lilly’s LY3549492 listing gives a concrete example of approximately 56 weeks and 14 visits. TRIUMPH-8 estimates about 65 weeks and 18 visits, while TRIUMPH-1 estimated about 89 weeks and up to 24 visits. These are different studies, not competing estimates for one standard trial; confirm the schedule for the specific listing and location.
For any study, HHS says consent information should explain the expected duration, procedures, experimental procedures, and reasonably foreseeable risks. Read the document and ask questions until the placebo possibility, visit burden, and contact process are clear.
Frequently Asked Questions
How long do Lilly weight-loss trials last, and how many clinic visits are involved?
The commitment varies by study. The Lilly listing for LY3549492 describes about 56 weeks and 14 visits; the TRIUMPH-8 listing estimates about 65 weeks and 18 visits, while TRIUMPH-1 estimated about 89 weeks and up to 24 visits. Confirm the current schedule with the study team.
Are current Lilly studies testing retatrutide, tirzepatide, or other weight-loss treatments?
The supplied listings include Lilly-sponsored retatrutide trials, including TRIUMPH-8 and TRIUMPH-1, and a Lilly weight-management listing for LY3549492. The TRIUMPH-8 listing is marked ACTIVE_NOT_RECRUITING, and TRIUMPH-1 is completed, so verify whether any study is currently enrolling before applying.
Can I leave a clinical trial after enrolling, and what happens if I do?
Yes. HHS says participation is voluntary and that participants may discontinue at any time without penalty or loss of benefits to which they are otherwise entitled. Ask the study team about any study-specific withdrawal steps, follow-up procedures, or consequences described in the consent form.
Sources
- Eli Lilly — Weight Management Research
- ClinicalTrials.gov — TRIUMPH-8 retatrutide trial (NCT07232719)
- ClinicalTrials.gov — TRIUMPH-1 retatrutide trial (NCT05929066)
- HHS Office for Human Research Protections — Informed Consent FAQs
- HHS Office for Human Research Protections — Questions to Ask About Volunteering for a Research Study
Disclaimer: This article is for general information only and is not medical advice. It is not a substitute for diagnosis or treatment by a qualified healthcare professional. Always speak to your doctor before acting on anything you read here.



